(Q39974466)

16 September 2017

CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo (English)

1 reference

16 September 2017

hepatocellular carcinoma

1 reference

1 reference

5

0 references

Veronika Lukacs-Kornek

2

object named as

Veronika Lukacs-Kornek

1 reference

16 September 2017

Maria A Gonzalez-Carmona

1

1 reference

16 September 2017

Anne Timmerman

3

1 reference

16 September 2017

Sara Shabani

4

1 reference

16 September 2017

Annabelle Vogt

6

1 reference

16 September 2017

Yildiz Yildiz

7

1 reference

16 September 2017

Elisabeth Sievers

8

1 reference

16 September 2017

Ingo G H Schmidt-Wolf

9

1 reference

16 September 2017

Wolfgang H Caselmann

10

1 reference

16 September 2017

Tilman Sauerbruch

11

1 reference

16 September 2017

Volker Schmitz

12

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 July 2008

1 reference

16 September 2017

1 reference

16 September 2017

48

1 reference

16 September 2017

157-168

1 reference

16 September 2017

1

1 reference

Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma

16 September 2017

1 reference

CD40L - a multipotent molecule for tumor therapy.

21 January 2018

1 reference

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

7 January 2021

Management of hepatocellular carcinoma

1 reference

7 January 2021

Dendritic cells and the control of immunity

1 reference

7 January 2021

Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells

1 reference

7 January 2021

Effective treatment of small murine hepatocellular carcinoma by dendritic cells

1 reference

7 January 2021

Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma

1 reference

7 January 2021

Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial

1 reference

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

1 reference

7 January 2021

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

1 reference

7 January 2021

Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10

1 reference

7 January 2021

Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma

1 reference

7 January 2021

Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.

1 reference

7 January 2021

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

7 January 2021

Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model

1 reference

7 January 2021

Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity

1 reference

7 January 2021

The key role of CD40 ligand in overcoming tumor-induced dendritic cell dysfunction

1 reference

7 January 2021

Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice

1 reference

7 January 2021

Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.

1 reference

7 January 2021

Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production

1 reference

7 January 2021

Transfection with CD40L induces tumour suppression by dendritic cell activation in an orthotopic mouse model of pancreatic adenocarcinoma.

1 reference

7 January 2021

Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets

1 reference

7 January 2021

An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy

1 reference

7 January 2021

Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor

1 reference

7 January 2021

Gene therapy of cancer with interleukin-12.

1 reference

7 January 2021

Is the liver an important site for the development of immune tolerance to tumours?

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.22296

1 reference

16 September 2017

1 reference